Skip to main navigation
Skip to search
Skip to main content
Sort by
Medicine and Dentistry
Adalimumab
25%
Adverse Event
13%
Angiomyolipoma
25%
Bevacizumab
50%
Cataract
16%
Cataract Surgery
12%
Cell Density
50%
Clinical Management
25%
Confocal Microscopy
28%
Corneal Transplantation
50%
Corneal Ulcer
25%
Corrected Distance Visual Acuity
25%
Craniotomy
25%
Diseases
45%
Dry Eye
60%
Endothelial Cell
50%
Eye Care
25%
Eye Disease
50%
Fatty Acid
25%
Fluorescein Angiography
25%
Glaucoma
35%
Graft Versus Host Reaction
100%
Infliximab
25%
Juvenile Idiopathic Arthritis
25%
Keratitis
31%
Liposarcoma
25%
Medical Record
12%
Multidetector Computed Tomography
25%
National Eye Institute Visual Function Questionnaire
25%
Observational Study
25%
Ocular Hypertension
25%
Ocular Surface Disease Index
16%
Patient Compliance
29%
Pediatrics
75%
Pediatrics Patient
13%
Phacoemulsification
25%
Placebo
33%
Postoperative Complication
18%
Prevalence
25%
Quality of Life
29%
Randomized Controlled Trial
25%
Retinal Vasculitis
28%
Rituximab
25%
Spontaneous Remission
25%
Stem Cell
29%
Steroid
40%
Supplementation
25%
Ulcer
29%
Uveitis
100%
Vernal Keratoconjunctivitis
75%
Nursing and Health Professions
Artificial Tear
6%
Bevacizumab
25%
Clinical Outcome
25%
Cornea Perforation
8%
Cornea Transplantation
25%
Debridement
9%
Diseases
25%
Dry Eye
16%
Eye Care
25%
Fluorescein
25%
Graft Versus Host Reaction
25%
Loteprednol
6%
Ocular Surface Disease Index
22%
Placebo
6%
Schirmer Test
25%
Staining
25%
Symptom Assessment
16%
Ulcer
29%
Vernal Conjunctivitis
50%